# Core Laboratories Inc. (CLB)

**Exchange:** NYSE  
**Market cap:** $623M  
**Price:** $13.25 (-1.27%)

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $527M | $109M | $56M | $30M | — |
| 2024 | $524M | $103M | $59M | $31M | — |
| 2023 | $510M | $110M | $55M | $37M | — |
| 2022 | $490M | $96M | $42M | $19M | — |
| 2021 | $470M | — | $45M | $20M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $584M | $318M | $266M | $23M | $113M |
| 2024 | $585M | $339M | $247M | $19M | $128M |
| 2023 | $586M | $362M | $225M | $15M | $166M |
| 2022 | $578M | $394M | $184M | $15M | $175M |
| 2021 | $581M | $420M | $161M | — | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $37M | $11M | $26M |
| 2024 | $56M | $12M | $45M |
| 2023 | $25M | $11M | $14M |
| 2022 | $25M | $10M | $15M |
| 2021 | $37M | $14M | $23M |

Source: [CompaniesByCap](https://companiesbycap.com/company/CLB)